Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours
Clinical trial NCT06453057 · RECRUITING
Trial details
- NCT number
- NCT06453057
- Sponsor
- Grit Biotechnology
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-04
- Primary completion
- 2027-06-06
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.